Rankings
▼
Calendar
SGHT
Sight Sciences, Inc.
$224M
Q2 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$20M
-8.5% YoY
Gross Profit
$17M
84.8% margin
Operating Income
-$12M
-59.6% margin
Net Income
-$12M
-61.0% margin
EPS (Diluted)
$-0.23
QoQ Revenue Growth
+11.7%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$122M
Total Liabilities
$52M
Stockholders' Equity
$70M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$20M
$21M
-8.5%
Gross Profit
$17M
$18M
-9.6%
Operating Income
-$12M
-$13M
+7.8%
Net Income
-$12M
-$12M
+3.1%
Revenue Segments
Surgical Glaucoma
$19M
98%
Dry Eye
$333,000
2%
← FY 2025
All Quarters
Q3 2025 →
SGHT Q2 2025 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena